Liver fibrosis secondary to bile duct injury: correlation of Smad7 with TGF-β and extracellular matrix proteins
Authors:
- María del Pilar Alatorre-CarranzaMAMaría del Pilar Alatorre-Carranza
- Alejandra Miranda-DíazAMAlejandra Miranda-Díaz
- Irinea Yañez-SánchezIYIrinea Yañez-Sánchez
- Oscar Pizano-MartínezOPOscar Pizano-Martínez
- José M Hermosillo-SandovalJHJosé M Hermosillo-Sandoval
- Mónica Vázquez-Del MercadoMMMónica Vázquez-Del Mercado
- Sebastián Hernández-HoyosSHSebastián Hernández-Hoyos
- Ricardo Martínez-AbundisRMRicardo Martínez-Abundis
- Mary Fafutis-MorrisMFMary Fafutis-Morris
- Jorge Segura-OrtegaJSJorge Segura-Ortega
- Vidal Delgado-RizoVDVidal Delgado-Rizo
Open Access
- 31 October 2009
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 9 (1) , 81
Abstract
Background: Liver fibrosis is the result of continuous liver injury stemming from different etiological factors. Bile duct injury induces an altered expression of TGF-β, which has an important role in liver fibrosis because this cytokine induces the expression of target genes such as collagens, PAI-1, TIMPs, and others that lead to extracellular matrix deposition. Smad7 is the principal inhibitor that regulates the target gene transcription of the TGF-β signaling. The aim of the study was to determine whether Smad7 mRNA expression correlates with the gene expression of TGF-β, Col I, Col III, Col IV, or PAI-1 in liver fibrosis secondary to bile duct injury (BDI). Results: Serum TGF-β concentration was higher in BDI patients (39 296 pg/ml) than in liver donors (9008 pg/ml). Morphometric analysis of liver sections showed 41.85% of tissue contained fibrotic deposits in BDI patients. mRNA expression of Smad7, Col I, and PAI-1 was also significantly higher (P < 0.05) in patients with BDI than in controls. Smad7 mRNA expression correlated significantly with TGF-β concentration, Col I and Col III expression, and the amount of fibrosis. Conclusion: We found augmented serum concentration of TGF-β and an increase in the percentage of fibrotic tissue in the liver of BDI patients. Contrary to expected results, the 6-fold increase in Smad7 expression did not inhibit the expression of TGF-β, collagens, and PAI-1. We also observed greater expression of Col I and Col III mRNA in BDI patients and significant correlations between their expression and TGF-β concentration and Smad7 mRNA expression.Keywords
This publication has 37 references indexed in Scilit:
- Elevated serum level and gene polymorphisms of TGF‐β1 in gastric cancerJournal of Clinical Laboratory Analysis, 2008
- Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex FormationMolecular and Cellular Biology, 2007
- HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-β1Experimental & Molecular Medicine, 2005
- Fine Tuning and Cross-talking of TGF-β Signal by Inhibitory SmadsBMB Reports, 2005
- Mexican infants with extrahepatic biliary atresia display different fibrosis activityHepatology Research, 2004
- Laparoscopic iatrogeny of the hepatic hilum as an indication for liver transplantationLiver Transplantation, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of SclerodermaJournal of Investigative Dermatology, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblastsFEBS Letters, 2001